Purchase this article with an account.
Jessica J. Kovarik, Lauren A. Willard, Evan L. Waxman; Diabetic Retinopathy Inpatient Study. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5741.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To investigate the prevalence of diabetic retinopathy (DR) among diabetic inpatients, a high-risk target population. More specifically, to determine the prevalence of undiagnosed DR and sight-threatening DR defined as severe non-proliferative diabetic retinopathy (NPDR), proliferative diabetic retinopathy (PDR) and clinically significant macular edema (CSME).
70 consecutive eligible inpatients with a known diagnosis of diabetes mellitus were enrolled in this cross-sectional study in a tertiary care center in Pittsburgh. Patients underwent retinal screening examination by digital photography of the posterior pole following pupillary dilation with 0.5% tropicamide. All photographs were analyzed independently by two ophthalmologists and severity of retinopathy was graded based on criteria established in the Early Treatment Diabetic Retinopathy study (ETDRS).
The overall prevalence of DR was 41%. The prevalence of sight-threatening DR was 22%. The prevalence of previously undiagnosed DR was 22%, of which 8.5% was sight-threatening.
The diabetic inpatient population is a high-risk group for undiagnosed diabetic retinopathy and should be targeted for ophthalmologic referral upon patient discharge.
This PDF is available to Subscribers Only